The free, open-source plug-in, an extensionfor Firefox, checks a library of scraped terms of service and privacy policies from dozens of major sites that updates every three hours.
Announcing the failure of the latest trial Tuesday, the two companies said they would halt development of Dimebon for all indications and cease an ongoing open-label extension study in Alzheimer's disease.